Rxivist logo

Cannabis is the most frequently used illicit psychoactive substance worldwide. Life time use has been reported among 35 to 40% of adults in Denmark and the United States. Cannabis use is increasing in the population and among users around 9% become dependent. The genetic risk component is high with heritability estimates of 51 to 70%. Here we report the first genome-wide significant risk locus for cannabis use disorder (CUD, P=9.31x10-12) that replicates in an independent population (Preplication=3.27x10-3, Pmetaanalysis=9.09x10-12). The finding is based on a genome-wide association study (GWAS) of 2,387 cases and 48,985 controls followed by replication in 5,501 cases and 301,041 controls. The index SNP (rs56372821) is a strong eQTL for CHRNA2 and analyses of the genetic regulated gene expressions identified significant association of CHRNA2 expression in cerebellum with CUD. This indicates a potential therapeutic use in CUD of compounds with agonistic effect on the neuronal acetylcholine receptor alpha-2 subunit encoded by CHRNA2. At the polygenic level analyses revealed a significant decrease in the risk of CUD with increased load of variants associated with cognitive performance.

Download data

  • Downloaded 1,738 times
  • Download rankings, all-time:
    • Site-wide: 10,526
    • In genomics: 1,096
  • Year to date:
    • Site-wide: 35,838
  • Since beginning of last month:
    • Site-wide: 60,639

Altmetric data

Downloads over time

Distribution of downloads per paper, site-wide